Unichem Laboratories: The financial results for the period ended September 30, 2026

What happened

Unichem Laboratories (UNICHEMLAB) filed a disclosure with the exchanges on 4 November 2026 at 01:54 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Unichem Laboratories is a small-cap company, with a market value of about ₹3,762 crore.

The stock last traded at ₹534.3, against a 52-week range of ₹278.2–₹687.2 (22.3% below the high).

Before this filing the shares had moved −5.9% over the month and +0.6% over three months. Average daily turnover over the last 20 sessions was about ₹2.38 crore.

Promoters held 70.22% at the end of Q1 FY27. Foreign institutions owned 0.90% and domestic institutions 10.46%.

What history shows

BCEIE's records show 1 previous results filing from the company since May 2026.

Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 4 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

• Unichem Laboratories: Creating a Niche Through Quality and Cost-Effective Generics with Reliable and Efficient Customer Service — Pharmacy Times, 26 Oct 2026
• Unichem Laboratories (UNICHEMLAB.NS) Slips 3.35% to ₹487.75 as Pharma Counter Retreats From Upper Band - Backspread Trade — https://www.siam.in/, 22 Oct 2026
• Unichem Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook — MarketsMojo, 27 Oct 2026
• Unichem Laboratories Q2 results: Net profit turns positive at Rs 22 crore, revenue rises 10.5% YoY — Business Upturn, 4 Nov 2026

Source

• Exchange filing (PDF)